Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Current Medical Research and Opinion|April 16, 2013
Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressantsJ Craig Nelson, Qianyi Zhang, Katarina Kelin, et al.
Australian Journal of General Practice|March 31, 2021
Prescribing and deprescribing in chronic kidney diseaseJo-Anne Manski-Nankervis, Rita McMorrow, Craig Nelson, et al.
Psychiatric Services (Washington, D.C.)|January 15, 2016
Mental Health Service Use Across the Life Course Among Adults With Psychiatric Disorders and Prior Suicidal BehaviorAmy L Byers, Amy X Lai, Patricia Arean, et al.
BMC Nephrology|October 2, 2013
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysisZaw Thet, Aung Ko Win, Eugenie Pedagogos, et al.
Nephrology (Carlton, Vic.)|February 19, 2024
Case report of the successful use of semaglutide to achieve target BMI prior to renal transplant in two patients with end-stage-kidney-diseaseRory Wallace, Peter Shane Hamblin, Emma Tully, et al.
The Permanente Journal|November 29, 2014
Upstream discussion provided in the ambulatory setting to assist patients with chronic kidney disease considering dialysisTuan K Le, Mi Chang, Craig Nelson, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 10, 2013
Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placeboMichael Robinson, Tina Myers Oakes, Joel Raskin, et al.
Journal of Law and Medicine|January 8, 2021
Clinical Decision Support Systems and Medico-Legal Liability in Recall and Treatment: A Fresh ExaminationMegan Prictor, Mark Taylor, Jane Kaye, et al.
Biological Psychiatry|June 26, 2007
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agentsGeorge I Papakostas, Michael E Thase, Maurizio Fava, et al.
Journal of the International Neuropsychological Society : JINS|August 7, 2019
Impaired Financial Capacity in Late-Life Depression: Revisiting Associations with Cognitive FunctioningRuth T Morin, Mitzi M Gonzales, David Bickford, et al.
Pageof 15